. . . . . "S&T TWOC Project - version 4" . "S&T TWOC version 3" . "2"^^ . "2023-07-20T09:47:16.793989"^^ . . . "for COVID-19 therapy" . "(336, 344)" . "considered" . "498" . "other antibiotics like azithromycin , ivermectin , eravacycline , valrubicin , streptomycin , nitazoxanide , teicoplanin , caspofungin , and colistin ; and other agents like hydroxychloroquine , chloroquine , tocilizumab , camostat , nafamostat , carfilzomib , interferon , aprepitant , and dexamethasone" . "(336, 344)" . "Results Repurposing of drugs from different pharmacological groups including antivirals like remdesivir, lopinavir, ritonavir, arbidol, oseltamivir, penciclovir, favipiravir, ganciclovir, and ribavirin; other antibiotics like azithromycin, ivermectin, eravacycline, valrubicin, streptomycin, nitazoxanide, teicoplanin, caspofungin, and colistin; and other agents like hydroxychloroquine, chloroquine, tocilizumab, camostat, nafamostat, carfilzomib, interferon, aprepitant, and dexamethasone can be considered for COVID-19 therapy." . "8j41d0a3" . "8j41d0a3-TRIPLE-ABSTRACT-2" . "colistin" . "covid-19" . "RSA" . "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" . "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" . . .